Screener
Clover Health Investments CLOV Stock-Based Comp
Stock-Based Comp at other companies
Other financials
Where this comes from
Reported directly by Clover Health Investments in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensation.
The source filing: Clover Health Investments’s 10-Q, filed May 8, 2026.
- Filed
- May 8, 2026, 8:06 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001801170-26-000122
| Line item | Three months ended March 31, 2026 | Three months ended March 31, 2025 |
|---|---|---|
| Net income (loss) | $27,334 | $(1,274) |
| Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: | ||
| Depreciation and amortization expense | 515 | 466 |
| Stock-based compensation | 12,271 | 26,437 |
| Accretion, net of amortization | (441) | (437) |
| Change in accrued interest earned | 141 | 540 |
| Net realized gains on investment securities | (28) | (42) |
| Changes in operating assets and liabilities: |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Clover Health Investments's stock-based comp?
- Clover Health Investments (CLOV) reported stock-based comp of $12.27M in Q1 2026.
- How has Clover Health Investments's stock-based comp changed year-over-year?
- Clover Health Investments's stock-based comp decreased by 53.6% year-over-year, from $26.44M to $12.27M.
- What is the long-term trend for Clover Health Investments's stock-based comp?
- Over 4 years (2021 to 2025), Clover Health Investments's stock-based comp has grown at a -10.8% compound annual growth rate (CAGR), from $163.72M to $103.66M.
- What does stock-based comp mean?
- Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.
Ask your AI about Clover Health Investments's stock-based comp.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude